Machine Learning-Based Virtual Screening and Molecular Modeling Reveal Potential Natural Inhibitors for Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer (NSCLC) is the most typical kind of lung cancer. Chemotherapy, radiation therapy, and other traditional cancer therapies are ineffective. Advancements in understanding cancer’s molecular causes have led to targeted therapies, such as those addressing NTRK gene fusions in N...
Saved in:
| Main Authors: | Zafer Saad Al Shehri, Faez Falah Alshehri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Crystals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4352/15/5/383 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case Report of Lung Adenocarcinoma with EGFR G719A Mutation
and LMNA-NTRK1 Fusion
by: Shiqi SONG, et al.
Published: (2025-01-01) -
Papillary thyroid cancer with translocation in the TPM3‑NTRK1 gene
by: M. R. Savchuk, et al.
Published: (2022-04-01) -
<i>NTRK</i> Gene Expression in Non-Small-Cell Lung Cancer
by: Jair Gutierrez-Herrera, et al.
Published: (2025-02-01) -
Identification of Potential Inhibitors of Histone Deacetylase 6 Through Virtual Screening and Molecular Dynamics Simulation Approach: Implications in Neurodegenerative Diseases
by: Anas Shamsi, et al.
Published: (2024-11-01) -
A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma
by: Hui Li, et al.
Published: (2024-10-01)